Preparation, stability studies and pharmacological behavior of [186Re]Re-HEDP

Applied Radiation and Isotopes

Volumn 51, Issue 1, 1999, Pages 51-58

  Kothari, K ^a   Pillai, M R A ^a   Unni, P R ^a   Shimpi, H H ^b   Noronha, O P D ^b   Samuel, A M ^b  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHARMACODYNAMICS; RADIOACTIVITY; RHENIUM;

BIODISTRIBUTION;

RADIOISOTOPES;

ETIDRONIC ACID RE 186; ETIDRONIC ACID TC 99M; RHENIUM 186;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; BONE METASTASIS; COOLING; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; MALE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; RAT; TISSUE DISTRIBUTION;

ANIMALS; CHROMATOGRAPHY, THIN LAYER; DRUG STABILITY; ETIDRONIC ACID; HYDROGEN-ION CONCENTRATION; ISOTOPE LABELING; MALE; ORGANOMETALLIC COMPOUNDS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RHENIUM; TISSUE DISTRIBUTION;

EID: 0033047977     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(98)00195-X     Document Type: Article

References (19)

1. 186Re complexes of 1-hydroxyethylidine-1,1-diphosphonate for treatment of painful osseous metastases Radioisotopes. 44:1995;514.
2. 186Re (Sn)-HEDP J. Radioanal. Nucl. Chem. Artic. 206:1996;43.
3. 186Re )Re(V)dimercaptosuccininc acid: A possible tumour radiotherapy agent Appl. Radiat. Isot. 42:1991;167.
4. Callahan A.P., Rice D.E., Knapp F.F. Jr. Rhenium-188 for therapeutic applications from an alumina based tungsten-188/rhenium-188 radionuclide generator. Nucl. Compact. 20:1989;3.
5. 99mTc labeled 1-hydroxy ehtylene-1,1-disodium phosphonate J. Nucl. Med. 13:1972;823.
6. Deutsch E., Libson K., Vanderheyden J.L., Ketring A.R., Maxon H.R. The chemistry of rhenium and technetium as related to the use of isotope of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13:1986;465.
7. Deutsch E., Heineman W.R., Zodda J.P., Gilbert T.W., Williams C.C. Preparation of no carrier added technetium-99m complexes: Determination of the total technetium contents of generator eluents. Int. J. Appl. Radiat. Isot. 33:1982;843.
8. Erhardt, G.J., Ketring, A.R., Turpin, T.A., Razavi, M.-S., Vanderheyden, J.-L., Su, F.-M. and Fritzberg, A.R., 1990. A convenient W-188/Re-188 generator for therapeutic applications using low specific activity W-188. In: Nicolini, M., Bandoli, G., Mazzi, U. (Eds.), Technetium and Rhenium in Chemistry and Nuclear Medicine, vol. 3. Raven Press, New York, pp. 631-634.
9. 186Re -perrhenate for nuclear medicine purposes Int. J. Appl. Radiat. Isot. 33:1982;99.
10. 188Re and a study of its stability Appl. Radiat. Isot. 49:1998;351.
11. de Klerk J.M.H., van het Schip A.D., Zonnenberg B.A., Dijk A.V., Quirijn J.M.S.P., Blijham G.H., van Rijk P.P. Phase I study of Rhenium-186-HEDP in patients with bone metastases originating from breast cancer. J. Nucl. Med. 37:1996;244.
12. 186Re complexes of dimercaptosuccinic acid and hydroxy ethylidine diphosphonate. In: Book of Abstracts of the 'International Symposium on Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy', pp. 94-95.
13. 188Re generators Appl. Radiat. Isot. 45:1994;1123.
14. Mathieu L., Chevalier P., Gely G., Berger M. Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. Int. J. Appl. Radiat. Isot. 30:1979;725.
15. Mausner L.F., Srivastava S.C. Selection of radionuleides for radioimmunotherapy. Med. Phys. 20:1993;503.
16. 186Re-(Sn)-HEDP for treatment of multiple metastatic foci in bone: Human biodistribution and dosimetric studies. Radiology 166, 501.
17. 186Re-(Sn)-HEDP for the treatment of painful osseous metastases: Initial clinical experience. In: Nicolini, M., Bandoli, G., Mazzi, U. (Eds.), Technetium and Rhenium in Chemistry and Nuclear Medicine. Raven Press, New York, pp. 733-739.
18. 188Re -(Sn)-HEDP for the treatment of osseous metastases J. Nucl. Med. 39:1998;659.
19. Vera-Ruiz H. Radiopharmaceuticals as therapeutic agents in medical care and treatment. IAEA Bull. 35:1993;633-659.